Test identifies patients at risk of complications following heart bypass surgery
This article was originally published in Clinica
US researchers have developed a non-invasive test which could predict a patient's risk of developing a life-threatening heart-rhythm abnormality, known as atrial fibrillation, following open heart-bypass surgery. The low-cost test could help doctors decide which patients would benefit from drug therapy before surgery and spare others the expense and side-effects associated with anti-arrhythmic drugs.
You may also be interested in...
Device Week, 4 December 2020 – MedWatch Question About Third-Party Servicers Slides Under Industry's Radar
On this week’s podcast: A change made by the US FDA to its MedWatch program that asks adverse event reporters whether a third party serviced a malfunctioning medical device went unnoticed by many in industry for nearly a year. We explain why, and tell how the servicer question will be helpful for manufacturers and the agency.
The series D financing will support the expansion of Everlywell’s consumer lab testing and digital health businesses.
New guidance from the UK regulator covers distribution and deployment of Pfizer/BioNTech's COVID-19 vaccine, which will be complex because of the temperature storage requirements and the large packs in which the vaccine doses will be delivered.